Cited by 652Phosphodiesterase function and regulationSchizophrenia research and treatmentProtein Tyrosine Phosphatases

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

Millar, J. Kirsty, Pickard, Benjamin S., Mackie, Shaun, James, Rachel, Christie, Sheila, Buchanan, Sebastienne R., Malloy, M. Pat, Chubb, Jennifer E., Huston, Elaine, Baillie, George S., Thomson, Pippa A., Hill, Elaine V., Brandon, Nicholas J., Rain, Jean-Christophe, Camargo, L. Miguel, Whiting, Paul J., Houslay, Miles D., Blackwood, Douglas H. R., Muir, Walter J., Porteous, David J.·2005·Science

DOI 10.1126/science.1112915

Open this paper in CoChat — free account

Abstract

The disrupted in schizophrenia 1 ( DISC1 ) gene is a candidate susceptibility factor for schizophrenia, but its mechanistic role in the disorder is unknown. Here we report that the gene encoding phosphodiesterase 4B ( PDE4B ) is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness. The PDEs inactivate adenosine 3′,5′-monophosphate (cAMP), a second messenger implicated in learning, memory, and mood. We show that DISC1 interacts with the UCR2 domain of PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from DISC1 and an increase in PDE4B activity. We propose a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP.

Integrity signals

Registry

Crossref · 10.1126/science.1112915

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254
Self-citation
PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization
Houslay, M. D., & Adams, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 768
Self-citation
Schizophrenia and Affective Disorders—Cosegregation with a Translocation at Chromosome 1q42 That Directly Disrupts Brain-Expressed Genes: Clinical and P300 Findings in a Family
Blackwood, D., Fordyce, A., Walker, M. T., Clair, D. M. S., Porteous, D. J., & Muir, W. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321969 · Cited by 734
Self-citation
Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase
Sette, C., & Conti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16526 · Cited by 412
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth
Miyoshi, K., Honda, A., Baba, K., Taniguchi, M., Oono, K., Fujita, T., Kuroda, S., Katayama, T., & Tohyama, M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001352 · Cited by 314
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
O’Donnell, J. M., & Zhang, H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.003 · Cited by 307
Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)
MacKenzie, S. J., Baillie, G. S., McPhee, I., MacKenzie, C., SEAMONS, R. A., McSorley, T., Millen, J. E., Beard, M., Heeke, G. V., & Houslay, M. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704743 · Cited by 261
Self-citation
Antidepressant-like Profile and Reduced Sensitivity to Rolipram in Mice Deficient in the PDE4D Phosphodiesterase Enzyme
Zhang, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00344-5 · Cited by 228
Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders
Brandon, N. J., Handford, E. J., Schurov, I., Rain, J., Pelling, M., Duran-Jimenez, B., Camargo, L. M., Oliver, K. R., Beher, D., Shearman, M. S., et al. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.09.009 · Cited by 224
Self-citation

Flagged first, then by citations

Show all 20 references

Research works printed but not linked: 2

C. P. Austin, L. Ma, B. Ky, J. A. Morris, P. J. Shugrue, Neuroreport14, 951 (2003).
H. T. Zhang et al., Neuropsychopharmacology27, 587 (2002).

Sorted by citations

Items 401–500 of 652

Animal Models of Schizophrenia
Lipska, B. K., & Gogos, J. A. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch22 · Cited by 19
Microglial circDlg1 modulates neuroinflammation by blocking PDE4B ubiquitination-dependent degradation associated with Alzheimer's disease
Shi, J., Song, C., Zhang, P., Wang, J., Huang, W., Yu, T., Wei, Z., Wang, L., Zhao, L., Zhang, R., et al. (2025) · Theranostics · doi:10.7150/thno.104709 · Cited by 18
Immunohistochemical evaluation of the GABAergic neuronal system in the prefrontal cortex of a DISC1 knockout mouse model of schizophrenia
Umeda, K., Iritani, S., Fujishiro, H., Sekiguchi, H., Torii, Y., Habuchi, C., Kuroda, K., Kaibuchi, K., & Ozaki, N. (2016) · Synapse · doi:10.1002/syn.21924 · Cited by 20
Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain
Ratta‐apha, W., Hishimoto, A., Mouri, K., Shiroiwa, K., Sasada, T., Yoshida, M., Supriyanto, I., Ueno, Y., Asano, M., Shirakawa, O., et al. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.08.010 · Cited by 18
Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases
Otero, C., Peñaloza, J. P., Rodas, P. I., Fernández‐Ramires, R., Velásquez, L., & Jung, J. E. (2014) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12080 · Cited by 18
Regulation of mitochondrial dynamics by DISC1, a putative risk factor for major mental illness
Murphy, L. C., & Millar, J. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.12.027 · Cited by 18
Self-citation
Compartmentalized cAMP Generation by Engineered Photoactivated Adenylyl Cyclases
O’Banion, C. P., Vickerman, B. M., Haar, L., & Lawrence, D. S. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.07.004 · Cited by 18
RNA Sequencing in Schizophrenia
Li, X., & Teng, S. (2015) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s28992 · Cited by 18
Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement
Wei, X., Yu, G., Shen, H., Luo, Y., Shang, T., Shen, R., Xi, M., & Sun, H. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106278 · Cited by 17
Allele-specific regulation of DISC1 expression by miR-135b-5p
Rossi, M., Kilpinen, H., Muona, M., Surakka, I. L., Ingle, C., Lahtinen, J., Hennah, W., Ripatti, S., & Hovatta, I. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.246 · Cited by 17
Role of Phosphodiesterase 4-Mediated Cyclic AMP Signaling in Pharmacotherapy for Substance Dependence
Wen, R.-T., Feng, W., Liang, J.-H., & Zhang, H. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826114412 · Cited by 17
Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies
Feng, Y., Dejun, C., Zhang, C., Li, Y., Zhang, Z., Wang, J., & Shi, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147092 · Cited by 17
PDE2 regulates membrane potential, respiration and permeability transition of rodent subsarcolemmal cardiac mitochondria
Liu, D., Wang, Z., Nicolas, V., Lindner, M., Mika, D., Vandecasteele, G., Fischmeister, R., & Brenner, C. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.05.002 · Cited by 17
MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3′UTR –12 bp to + 154 bp
Wu, X., Xu, F., Xia, X., Wang, B., & Yao, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1703729 · Cited by 17
Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex
Fatemi, S. H., Folsom, T. D., Reutiman, T. J., Braun, N. N., & Lavergne, L. G. (2010) · Synapse · doi:10.1002/syn.20762 · Cited by 17
Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study
Rezaei, F., Mesgarpour, B., Jeddian, A., Zeionoddini, A., Mohammadinejad, P., Salardini, E., Shahriari, M., Zeinoddini, A., & Akhondzadeh, S. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2583 · Cited by 17
The NDE1 genomic locus can affect treatment of psychiatric illness through gene expression changes related to microRNA-484
Bradshaw, N. J., Ukkola‐Vuoti, L., Pankakoski, M., Zheutlin, A. B., Ortega‐Alonso, A., Torniainen‐Holm, M., Sinha, V., Therman, S., Paunio, T., Suvisaari, J., et al. (2017) · Open Biology · doi:10.1098/rsob.170153 · Cited by 17
Association analysis of ATF4 and ATF5, genes for interacting-proteins of DISC1, in bipolar disorder
Kakiuchi, C., Ishiwata, M., Nanko, S., Kunugi, H., Minabe, Y., Nakamura, K., Mori, N., Fujii, K., Yamada, K., Yoshikawa, T., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.054 · Cited by 17
Schizophrenia Susceptibility Genes: in Search of A Molecular Logic and Novel Drug Targets for A Devastating Disorder
Gogos, J. A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78013-8 · Cited by 17
Conformational heterogeneity coupled with β-fibril formation of a scaffold protein involved in chronic mental illnesses
Cukkemane, A., Becker, N., Zielinski, M., Frieg, B., Lakomek, N., Heise, H., Schroeder, G. F., Willbold, D., & Weiergräber, O. H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01765-1 · Cited by 14
Comparative single-cell multiome identifies evolutionary changes in neural progenitor cells during primate brain development
Liu, Y., Luo, X., Sun, Y., Chen, K., Hu, T., You, B., Xu, J., Zhang, F., Cheng, Q., Meng, X., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.10.005 · Cited by 18
DISC1 and Huntington's Disease – Overlapping Pathways of Vulnerability to Neurological Disorder?
Boxall, R., Porteous, D., & Thomson, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016263 · Cited by 31
Self-citation
Selective Fluorogenic Chemosensors for Distinct Classes of Nucleases
Jung, J., Edwards, S. K., & Kool, E. T. (2013) · ChemBioChem · doi:10.1002/cbic.201300001 · Cited by 16
Psychiatric aspects of phosphodiesterases: An overview
Mangot, A. G., & Murthy, V. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.169593 · Cited by 16
A primary candidate gene for obsessive-compulsive disorder.
Leckman, J., & Kim, Y.-S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.717 · Cited by 14
Survey of Schizophrenia and Bipolar Disorder Candidate Genes using Chromatin Immunoprecipitation and Tiled Microarrays (ChIP-chip)
Pedrosa, E., Locker, J. D., & Lachman, H. M. (2009) · Journal of Neurogenetics · doi:10.1080/01677060802669766 · Cited by 16
RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5
Bolger, G. B. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.08.003 · Cited by 15
Copy variations in schizophrenia and bipolar disorder
Lachman, H. M. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184689 · Cited by 15
Interactions of human truncated DISC1 proteins: implications for schizophrenia
Newburn, E. N., Hyde, T. M., Ye, T., Morita, Y., Weinberger, D. R., Kleinman, J. E., & Lipska, B. K. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.31 · Cited by 15
Local Termination of 3′-5′-Cyclic Adenosine Monophosphate Signals: The Role of A Kinase Anchoring Protein–Tethered Phosphodiesterases
Stangherlin, A., & Zaccolo, M. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182214f2b · Cited by 15
How DISC1 regulates postnatal brain development: girdin gets in on the AKT.
Porteous, D., & Millar, K. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.017 · Cited by 24
Self-citation
Methodological Issues in Molecular Genetic Studies of Mental Disorders
Bearden, C. E., Jasinska, A. J., & Freimer, N. B. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153545 · Cited by 15
An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis
Kamath, V. J., Moberg, P. J., Calkins, M. E., Borgmann‐Winter, K. E., Conroy, C. G., Gur, R. E., Kohler, C. G., & Turetsky, B. I. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.029 · Cited by 15
Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior
Bolger, G. B., Smoot, L. H. M., & van Groen, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165704 · Cited by 14
Translational relevance of forward genetic screens in animal models for the study of psychiatric disease
Sheardown, E., Mech, A. M., Petrazzini, M. E. M., Leggieri, A., Gidziela, A., Hosseinian, S., Sealy, I. M., Torres-Pérez, J. V., Busch‐Nentwich, E. M., Malanchini, M., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104559 · Cited by 13
The D2R-DISC1 protein complex and associated proteins are altered in schizophrenia and normalized with antipsychotic treatment
Wang, J.-J., Su, P., Yang, J., Xu, L.-H., Yuan, A.-H., Li, C.-B., Zhang, T.-H., Dong, F., Zhou, J.-J., Samsom, J. N., et al. (2022) · Journal of Psychiatry & Neuroscience · doi:10.1503/jpn.210145 · Cited by 12
Paper-based inkjet bioprinting to detect fluorescence resonance energy transfer for the assessment of anti-inflammatory activity
Samson, A. A. S., Lee, J.-M., & Song, J. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18995-3 · Cited by 14
Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia
Matsuzaki, S., & Tohyama, M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1097 · Cited by 13
Phosphodiesterase 4D, cAMP specific
Houslay, M. D., & Conti, M. (2010) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000106.01 · Cited by 13
Self-citation
Pleiotropic Locus for Emotion Recognition and Amygdala Volume Identified Using Univariate and Bivariate Linkage
Knowles, E. E. M., McKay, D., Kent, J. W., Sprooten, E., Carless, M. A., Curran, J. E., Almeida, M., Dyer, T. D., Göring, H. H. H., Olvera, R. L., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14030311 · Cited by 13
Stimulation of Synaptic Vesicle Exocytosis by the Mental Disease Gene DISC1 is Mediated by N-Type Voltage-Gated Calcium Channels
Tang, W., Thevathasan, J. V., Lin, Q., Lim, K. B., Kuroda, K., Kaibuchi, K., Bilger, M., Soong, T. W., & Fivaz, M. L. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00015 · Cited by 14
Database of genetic studies of bipolar disorder
Piletz, J. E., Zhang, X., Ranade, R., & Liu, C. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328341a346 · Cited by 13
The current and potential impact of genetics and genomics on neuropsychopharmacology
Harrison, P. J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.02.005 · Cited by 14
Altered Disrupted-in-Schizophrenia-1 Function Affects the Development of Cortical Parvalbumin Interneurons by an Indirect Mechanism
Borkowska, M., Millar, J. K., & Price, D. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156082 · Cited by 15
Self-citation
Interaction of Cdk5 and cAMP/PKA Signaling in the Mediation of Neuropsychiatric and Neurodegenerative Diseases
Hu, Y., Pan, S., & Zhang, H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_3 · Cited by 13
Association study of PDE4B with panic disorder in the Japanese population
Otowa, T., Kawamura, Y., Sugaya, N., Yoshida, E., Shimada, T., Liu, X., Tochigi, M., Umekage, T., Miyagawa, T., Nishida‐Aoki, N., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.013 · Cited by 13
A functional polymorphism in the disrupted-in schizophrenia 1 gene is associated with chronic fatigue syndrome
Fukuda, S., Hashimoto, R., Ohi, K., Yamaguti, K., Nakatomi, Y., Yasuda, Y., Kamino, K., Takeda, M., Tajima, S., Kuratsune, H., et al. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.03.007 · Cited by 13
Latent toxoplasmosis impairs learning and memory yet strengthens short-term and long-term hippocampal synaptic plasticity at perforant pathway-dentate gyrus, and Schaffer collatterals-CA1 synapses
Choopani, S., Kiani, B., Aliakbari, S., Babaie, J., Golkar, M., Pourbadie, H. G., & Sayyah, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-35971-2 · Cited by 12
Adolescent psychosocial stress enhances sensitization to cocaine exposure in genetically vulnerable mice
Hikida, T., Morita, M., Kuroiwa, M., Macpherson, T., Shuto, T., Sotogaku, N., Niwa, M., Sawa, A., & Nishi, A. (2019) · Neuroscience Research · doi:10.1016/j.neures.2019.02.007 · Cited by 12
Modelling disrupted-in-schizophrenia 1 loss of function in human neural progenitor cells: tools for molecular studies of human neurodevelopment and neuropsychiatric disorders
Kobayashi, N., Sui, L., Tan, P. S. L., Lim, E. K. H., Chan, J. K. Y., Choolani, M. A., & Crook, J. M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.131 · Cited by 12
Update on psychiatric genetics
Zuchner, S. L., Roberts, S. T., Speer, M. C., & Beckham, J. C. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e318065a9fa · Cited by 13
Schizophrenia: genetics, prevention and rehabilitation
Olgiati, P., Mandelli, L., Lorenzi, C., Marino, E., Pirovano, A., Ferrari, B., Ronchi, D. D., & Serretti, A. (2009) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00360.x · Cited by 12
Interaction between DISC1 and CHL1 in regulation of neurite outgrowth
Ren, J., Zhao, T., Xu, Y., & Ye, H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.033 · Cited by 12
The XVth World Congress of Psychiatric Genetics, October 7–11, 2007: Rapporteur summaries of oral presentations
Alkelai, A., Baum, A. E., Carless, M. A., Crowley, J. J., DasBanerjee, T., Dempster, E. L., Docherty, S. J., Hare, E., Galsworthy, M. J., Grover, D., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30711 · Cited by 12
Molecular genetic studies of cognitive deficit in schizophrenia
Голимбет, В. Е. (2008) · Molecular Biology · doi:10.1134/s0026893308050117 · Cited by 11
Distinctively lower DISC1 mRNA levels in patients with schizophrenia, especially in those with higher positive, negative, and depressive symptoms
Chen, Y.-M., Lin, C., & Lane, H. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173335 · Cited by 11
Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics
Eiden, L. E., Goosens, K. A., Jacobson, K. A., Leggio, L., & Zhang, L. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00017 · Cited by 11
Molecular characterization of an interstitial deletion of 1p31.3 in a patient with obesity and psychiatric illness and a review of the literature
Petti, M., Samanich, J. M., Pan, Q., Huang, C.-K., Reinmund, J., Farooqi, I. S., Morrow, B. E., & Babcock, M. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33869 · Cited by 11
Phosphodiesterase inhibitors—Are they potential neuroleptic drugs?
Becker, A., & Grecksch, G. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.002 · Cited by 11
Primate-Accelerated Evolutionary Genes: Novel Routes to Drug Discovery in Psychiatric Disorders
Moalic, J., Strat, Y. L., Lepagnol-Bestel, A.-M., Ramoz, N., Loe-Mie, Y., Maussion, G., Gorwood, P. A. P. M., & Simonneau, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790936338 · Cited by 12
Chromosomal abnormalities and psychosis
Muir, W. J., Pickard, B. S., & Blackwood, D. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023895 · Cited by 11
Self-citation
Epigenetic regulation of human-specific gene expression in the prefrontal cortex
Sun, W., Xie, G., Jiang, X., Khaitovich, P., Han, D., & Liu, X. (2023) · BMC Biology · doi:10.1186/s12915-023-01612-3 · Cited by 12
In the Brain of Phosphodiesterases: Potential Therapeutic Targets for Schizophrenia
Barbagallo, F., Assenza, M. R., & Messina, A. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1229 · Cited by 12
Use of biomarkers in the discovery of novel anti-schizophrenia drugs
Mikkelsen, J. D., Thomsen, M. S., Hansen, H. H., & Lichota, J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.12.004 · Cited by 10
Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus
Hofeditz, T., Unsin, C. E.-M., Wiese, J., Imhoff, J. F., Wohlleben, W., Grond, S., & Weber, T. (2018) · Antibiotics · doi:10.3390/antibiotics7030053 · Cited by 10
Variants in regulatory elements of PDE4D associate with major mental illness in the Finnish population
Sinha, V., Ukkola‐Vuoti, L., Ortega‐Alonso, A., Torniainen‐Holm, M., Therman, S., Tuulio‐Henriksson, A., Jylhä, P. J., Kaprio, J. A., Hovatta, I., Isometsä, E. T., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0429-x · Cited by 10
Noradrenergic Suppression of Persistent Firing in Hippocampal CA1 Pyramidal Cells through cAMP-PKA Pathway
Valero-Aracama, M. J., Reboreda, A., Arboit, A., Sauvage, M. M., & Yoshida, M. (2021) · eNeuro · doi:10.1523/eneuro.0440-20.2020 · Cited by 10
Phosphodiesterase Type 5 as a Candidate Therapeutic Target in Cancers
Barone, I., Giordano, C., Bonofiglio, D., Catalano, S., & Andò, S. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0083-1 · Cited by 10
Drug discovery based on genetic and metabolic findings in schizophrenia
Dwyer, D. S., Weeks, K. R., & Aamodt, E. J. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.6.773 · Cited by 10
Cellular Functions of PDE4 Enzymes
Bolger, G. B., Conti, M., & Houslay, M. D. (2006) · CRC Press eBooks · doi:10.1201/9781420020847-6 · Cited by 10
Self-citation
Mouse Mutagenesis and Disease Models for Neuropsychiatric Disorders
Gondo, Y., Murata, T., Makino, S., Fukumura, R., & Ishitsuka, Y. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_106 · Cited by 11
Mutations in DISC1 alter IP3R and voltage-gated Ca2+ channel functioning, implications for major mental illness
Rittenhouse, A. R., Ortiz-Miranda, S., & Jurczyk, A. (2021) · Neuronal Signaling · doi:10.1042/ns20180122 · Cited by 10
SNAT1 and a family with high rates of suicidal behavior
Ernst, C., Dumoulin, P. C., Cabot, S., Erickson, J. D., & Turecki, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.010 · Cited by 9
The Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory Loss
Hansen, R., & Zhang, H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_7 · Cited by 9
Multi-Scale Understanding of NMDA Receptor Function in Schizophrenia
Hyun, J. S., Inoue, T., & Hayashi‐Takagi, A. (2020) · Biomolecules · doi:10.3390/biom10081172 · Cited by 9
Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of psychosis
Vázquez-Bourgon, J., Roiz-Santiañez, R., Papiol, S., Ferro, A., Varela-Gómez, N., Fañanás, L., & Crespo-Facorro, B. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9433-1 · Cited by 8
Neuroprotection and Enhancement of Neurite Outgrowth With Small Molecular Weight Compounds From Screens of Chemical Libraries
Dwyer, D. S., & Dickson, A. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77008-8 · Cited by 9
Microdeletion 19p13.2 in an almost 5‐year‐old boy
Haberlandt, E., Spreiz, A., Sigl, S. B., Janetschek, C., Röthlisberger, B., Zotter, S., Rostasy, K. M., Zschocke, J., & Kotzot, D. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35291 · Cited by 9
Fault Diagnosis Engineering in Molecular Signaling Networks: An Overview and Applications in Target Discovery
Abdi, A., & Emamian, E. S. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900315 · Cited by 9
DISC1 mRNA expression is not influenced by common Cis‐acting regulatory polymorphisms or imprinting
Hayesmoore, J. B. G., Bray, N. J., Owen, M., & O’Donovan, M. C. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30715 · Cited by 9
Arrestin Times for Developing Antipsychotics and β-Blockers
Houslay, M. D. (2009) · Science Signaling · doi:10.1126/scisignal.266pe22 · Cited by 9
Self-citation
5.3 Dopamine’s Influence on Prefrontal Cortical Cognition: Actions and Circuits in Behaving Primates
Arnsten, A. F. T., Vijayraghavan, S., Wang, M., Gamo, N. J., & Paspalas, C. D. (2009) · Dopamine Handbook · doi:10.1093/acprof:oso/9780195373035.003.0016 · Cited by 23
Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia
Lu, J. Y., Tiwari, A. K., Zai, G. C., Rastogi, A., Shaikh, S. A., Müller, D. J., Voineskos, A. N., Potkin, S. G., Lieberman, J. A., Meltzer, H. Y., et al. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.007 · Cited by 8
PDE4B Missense Variant Increases Susceptibility to Post-traumatic Stress Disorder-Relevant Phenotypes in Mice
Lipina, T. V., Li, S., Петрова, Е. С., Amstislavskaya, T. G., Cameron, R. T., Elliott, C., Gondo, Y., McGirr, A., Mullins, J. G. L., Baillie, G. S., et al. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.0137-24.2024 · Cited by 10
Self-citation
Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors
Jóźwiak-Bębenista, M., & Kowalczyk, E. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2127-2 · Cited by 8
Arrestin-Dependent Localization of Phosphodiesterases
Willis, M. J., & Baillie, G. S. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_15 · Cited by 8
Self-citation
The Applications of Pharmacogenomics to Neurological Disorders
Gilman, C., McSweeney, C., & Mao, Y. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666140811115900 · Cited by 9
d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner
Svane, K. C., Asis, E.-K., Omelchenko, A., Kunnath, A. J., Brzustowicz, L. M., Silverstein, S. M., & Firestein, B. L. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.03.011 · Cited by 8
A DISC1 point mutation promotes oligomerization and impairs information processing in a mouse model of schizophrenia
Kakuda, K., Niwa, A., Honda, R. P., Yamaguchi, K., Tomita, H., Nojebuzzaman, M., Hara, A., Goto, Y., Osawa, M., & Kuwata, K. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy116 · Cited by 8
Genetische Befunde zu Schizophrenie
Mehler‐Wex, C., & Renner, T. (2008) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.36.1.17 · Cited by 8
Phosphodiesterase 4A, cAMP specific
Houslay, M. D. (2006) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000104.01 · Cited by 7
Self-citation
Dendrobine and Erianin alleviate inflammation-induced depressive-like behaviors by targeting phosphodiesterase 4B in adolescent mice
Shi, J., Wang, J., Cao, H., Song, Y., Lu, Y., Zhang, Y., Li, J., Chen, Y., Zhang, Y., Wang, L., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157230 · Cited by 7
Defined co-cultures of glutamatergic and GABAergic neurons with a mutation in DISC1 reveal aberrant phenotypes in GABAergic neurons
Heider, J., Stahl, A., Sperlich, D., Hartmann, S.-M., Vogel, S., Breitmeyer, R., Templin, M. F., & Volkmer, H. (2024) · BMC Neuroscience · doi:10.1186/s12868-024-00858-z · Cited by 7
The Importance of Glia in Dealing with Stress
Woodbury-Fariña, M. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.08.003 · Cited by 7
Schizophrenia: Modeling a complex psychiatric disorder
Arguello, P. A., & Gogos, J. A. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.12.004 · Cited by 7
Switching DISC1 Function in Neurogenesis: Dixdc1 Selects DISC1 Binding Partners
Namba, T., & Kaibuchi, K. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.07.002 · Cited by 7
Proteomic Studies Reveal Disrupted in Schizophrenia 1 as a Player in Both Neurodevelopment and Synaptic Function
Ramos, A., Rodríguez-Seoane, C., Rosa, I., Gorroño‐Etxebarria, I., Alonso, J., Veiga, S., Korth, C., Kypta, R., García, Á., & Requena, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010119 · Cited by 6
A Latent Gaussian Copula Model for Mixed Data Analysis in Brain Imaging Genetics
Zhang, A., Fang, J., Hu, W., Calhoun, V. D., & Wang, Y. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2950904 · Cited by 7
Assays for Cyclic Nucleotide‐Specific Phosphodiesterases (PDEs) in the Central Nervous System (PDE1, PDE2, PDE4, and PDE10)
Deng, C., Wang, D., Bugaj‐Gaweda, B., & Vivo, M. D. (2007) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0721s38 · Cited by 7
Taking a bird's eye view on a mouse model review: a comparison of findings from mouse models targeting DISC1 or DISC1-interacting proteins
Kelly, M. P., & Brandon, N. (2011) · Future Neurology · doi:10.2217/fnl.11.39 · Cited by 15
Self-citation

Authors: Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., Thomson, P. A., Hill, E. V., Brandon, N. J., Rain, J.-C., Camargo, L. M., Whiting, P. J., Houslay, M. D., Blackwood, D. H. R., Muir, W. J., & Porteous, D. J.
Affiliations: Royal Edinburgh Hospital (GB)
Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh EH4 2XU, UK.
Corresponding author: Millar, J. Kirsty
ORCID: James, Rachel
Baillie, George S.
Thomson, Pippa A.
Brandon, Nicholas J.
Rain, Jean-Christophe
Camargo, L. Miguel
Whiting, Paul J.
Houslay, Miles D.
Blackwood, Douglas H. R.
Porteous, David J.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2005-11-18
Volume: 310
Issue: 5751
Pages: 1187-1191
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1112915
OpenAlex: W2105051672
Cited by: 648
References: 20
Citations by year: 2026: 7 · 2025: 7 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 13 · 2020: 14 · 2019: 19 · 2018: 21 · 2017: 24 · 2016: 28 · 2015: 47 · 2014: 39 · 2013: 24 · 2012: 35
FWCI: 20.82
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Wellcome Trust
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords: DISC1, PDE4B, schizophrenia, cAMP signaling, phosphodiesterase 4, balanced translocation, protein-protein interaction, second messengers, genetic susceptibility, chronic mental illness
MeSH terms: Cyclic AMP, Adult, Affective Disorders, Psychotic, Animals, Cell Line, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 16, Enzyme Activation, Humans, Male, Nerve Tissue Proteins, Protein Binding, Schizophrenia, Translocation, Genetic, 3',5'-Cyclic-AMP Phosphodiesterases, Signal Transduction, Cadherins, Genetic Predisposition to Disease, Rats, Cyclic Nucleotide Phosphodiesterases, Type 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks